journal article·2025-05-12Open access

Matrix Stiffness and Biochemistry Govern Colorectal Cancer Cell Growth and Signaling in User-Programmable Synthetic Hydrogels

Irina Kopyeva, Ross C. Bretherton, Jessica L. Ayers, Ming Yu, William M. Grady, Cole A. DeForest

Abstract

Colorectal cancer (CRC) studies in vitro have been conducted almost exclusively on 2D cell monolayers or suspension spheroid cultures. Though these platforms have shed light on many important aspects of CRC biology, they fail to recapitulate essential cell-matrix interactions that often define in vivo function. Toward filling this knowledge gap, synthetic hydrogel biomaterials with user-programmable matrix mechanics and biochemistry have gained popularity for culturing cells in a more physiologically relevant 3D context. Here, using a poly(ethylene glycol)-based hydrogel model, we systematically assess the role of matrix stiffness and fibronectin-derived RGDS adhesive peptide presentation on CRC colony morphology and proliferation. Highlighting platform generalizability, we demonstrate that these hydrogels can support the viability and promote spontaneous spheroid or multicellular aggregate formation of six CRC cell lines that are commonly utilized in biomedical research. These gels are engineered to be fully degradable via a "biologically invisible" sortase-mediated reaction, enabling the triggered recovery of single cells and spheroids for downstream analysis. Using these platforms, we establish that substrate mechanics play a significant role in colony growth: soft conditions (∼300 Pa) encourage robust colony formation, whereas stiffer (∼2 kPa) gels severely restrict growth. Tuning the RGDS concentration did not affect the colony morphology. Additionally, we observe that epidermal growth factor receptor (EGFR) signaling in Caco-2 cells is influenced by adhesion ligand identity─whether the adhesion peptide was derived from collagen type I (DGEA) or fibronectin (RGDS)─with DGEA yielding a marked decrease in the level of downstream protein kinase phosphorylation. Taken together, this study introduces a versatile method to culture and probe CRC cell-matrix interactions within engineered 3D biomaterials.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: 3D Printing in Biomedical Research · Cellular Mechanics and Interactions · Hydrogels: synthesis, properties, applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Bioengineering

University of Washington

Institute of Stem Cell & Regenerative Medicine

Translational Science and Therapeutics Division

Fred Hutchinson Cancer Center

Department of Internal Medicine

Department of Chemical Engineering

Funding

Division of Cancer Prevention, National Cancer Institute · Division of Graduate Education · National Institute of General Medical Sciences · Division of Materials Research

References (92)

Show source-provided references
1. 10.3322/caac.2160110.3322/caac.21601 ↗
2. 10.1016/j.ccell.2020.05.00510.1016/j.ccell.2020.05.005 ↗
3. 10.1001/jama.2021.010610.1001/jama.2021.0106 ↗
4. 10.1038/nature1115610.1038/nature11156 ↗
5. 10.1002/jcp.2565810.1002/jcp.25658 ↗
6. 10.1016/j.semcancer.2020.06.00410.1016/j.semcancer.2020.06.004 ↗
7. 10.3390/cancers1405122510.3390/cancers14051225 ↗
8. 10.1016/j.critrevonc.2022.10371210.1016/j.critrevonc.2022.103712 ↗
9. 10.1016/j.biomaterials.2016.11.03410.1016/j.biomaterials.2016.11.034 ↗
10. Gulubova M. V. · Neoplasma · 2006 · 53 · 372
11. 10.1074/jbc.RA118.00508710.1074/jbc.RA118.005087 ↗
12. 10.1186/1471-2407-14-51810.1186/1471-2407-14-518 ↗
13. 10.1038/nmat261910.1038/nmat2619 ↗
14. 10.1021/acsbiomaterials.0c0154910.1021/acsbiomaterials.0c01549 ↗
15. 10.1002/admi.20200119810.1002/admi.202001198 ↗
16. 10.1016/j.actbio.2024.02.01010.1016/j.actbio.2024.02.010 ↗
17. 10.1016/j.matt.2023.10.01210.1016/j.matt.2023.10.012 ↗
18. 10.1002/jbm.a.3761110.1002/jbm.a.37611 ↗
19. 10.1039/c7ib00128b10.1039/c7ib00128b ↗
20. 10.1038/s41467-021-25921-910.1038/s41467-021-25921-9 ↗
21. 10.1038/nmat247310.1038/nmat2473 ↗
22. 10.1038/nmat421910.1038/nmat4219 ↗
23. 10.1186/s12943-017-0691-y10.1186/s12943-017-0691-y ↗
24. 10.1002/adma.20220990410.1002/adma.202209904 ↗
25. 10.1038/nchem.291710.1038/nchem.2917 ↗
26. 10.1146/annurev-bioeng-060418-05232410.1146/annurev-bioeng-060418-052324 ↗
27. 10.1016/j.tibs.2024.04.00310.1016/j.tibs.2024.04.003 ↗
28. 10.1016/j.biomaterials.2017.03.03010.1016/j.biomaterials.2017.03.030 ↗
29. 10.1016/j.biomaterials.2020.12012510.1016/j.biomaterials.2020.120125 ↗
30. 10.1002/adma.20240488010.1002/adma.202404880 ↗
31. 10.1016/j.actbio.2021.06.02810.1016/j.actbio.2021.06.028 ↗
32. 10.1016/j.xpro.2020.10009810.1016/j.xpro.2020.100098 ↗
33. 10.1186/s12859-021-04344-910.1186/s12859-021-04344-9 ↗
34. 10.1038/nmeth.201910.1038/nmeth.2019 ↗
35. 10.1021/pr200561710.1021/pr2005617 ↗
36. 10.1146/annurev-cancerbio-050216-03443110.1146/annurev-cancerbio-050216-034431 ↗
37. 10.1007/s10555-008-9173-410.1007/s10555-008-9173-4 ↗
38. 10.1016/j.biomaterials.2017.02.00410.1016/j.biomaterials.2017.02.004 ↗
39. 10.1038/309030a010.1038/309030a0 ↗
40. 10.1073/pnas.141117911110.1073/pnas.1411179111 ↗
41. 10.1016/j.actbio.2018.11.01110.1016/j.actbio.2018.11.011 ↗
42. 10.1038/nrdp.2015.6510.1038/nrdp.2015.65 ↗
43. 10.3748/wjg.v13.i44.587710.3748/wjg.v13.i44.5877 ↗
44. 10.1016/S1470-2045(05)70168-610.1016/S1470-2045(05)70168-6 ↗
45. 10.1016/j.cellimm.2009.07.00410.1016/j.cellimm.2009.07.004 ↗
46. 10.1083/jcb.135.6.163310.1083/jcb.135.6.1633 ↗
47. 10.1074/jbc.M10910120010.1074/jbc.M109101200 ↗
48. 10.1016/j.ccell.2018.11.01610.1016/j.ccell.2018.11.016 ↗
49. 10.1128/MCB.24.19.8586-8599.200410.1128/MCB.24.19.8586-8599.2004 ↗
50. 10.1557/s43578-021-00423-y10.1557/s43578-021-00423-y ↗
51. 10.1016/S0021-9258(20)89455-110.1016/S0021-9258(20)89455-1 ↗
52. 10.1371/journal.pone.005968910.1371/journal.pone.0059689 ↗
53. 10.1016/j.actbio.2017.08.03510.1016/j.actbio.2017.08.035 ↗
54. 10.1038/ncb120910.1038/ncb1209 ↗
55. 10.1016/j.cell.2006.09.02610.1016/j.cell.2006.09.026 ↗
56. 10.1002/msb.13470810.1002/msb.134708 ↗
57. 10.1016/j.celrep.2017.04.04810.1016/j.celrep.2017.04.048 ↗
58. 10.1073/pnas.110403010810.1073/pnas.1104030108 ↗
59. 10.34133/bmef.000610.34133/bmef.0006 ↗
60. 10.1002/adhm.20170116510.1002/adhm.201701165 ↗
61. 10.1002/mabi.20150011010.1002/mabi.201500110 ↗
62. 10.1038/s44222-023-00105-w10.1038/s44222-023-00105-w ↗
63. 10.1002/adhm.20190155310.1002/adhm.201901553 ↗
64. 10.1126/sciadv.aas899810.1126/sciadv.aas8998 ↗
65. 10.1002/anie.20161035310.1002/anie.201610353 ↗
66. 10.1016/j.carbpol.2023.12079010.1016/j.carbpol.2023.120790 ↗
67. 10.1016/j.biomaterials.2018.12.01610.1016/j.biomaterials.2018.12.016 ↗
68. 10.1002/adma.20190536610.1002/adma.201905366 ↗
69. 10.1038/s44222-024-00234-w10.1038/s44222-024-00234-w ↗
70. 10.1152/japplphysiol.01143.200110.1152/japplphysiol.01143.2001 ↗
71. 10.1038/s41563-021-01085-110.1038/s41563-021-01085-1 ↗
72. 10.1002/advs.20250114810.1002/advs.202501148 ↗
73. 10.1038/oncsis.2013.3510.1038/oncsis.2013.35 ↗
74. 10.1016/j.biomaterials.2018.01.01210.1016/j.biomaterials.2018.01.012 ↗
75. 10.1039/C7BM00691H10.1039/C7BM00691H ↗
76. 10.1021/acs.biomac.0c0128710.1021/acs.biomac.0c01287 ↗
77. 10.1016/j.biomaterials.2011.08.04510.1016/j.biomaterials.2011.08.045 ↗
78. 10.1038/nmat336110.1038/nmat3361 ↗
79. 10.1126/scitranslmed.aao047510.1126/scitranslmed.aao0475 ↗
80. 10.1016/j.cell.2009.10.02710.1016/j.cell.2009.10.027 ↗
81. 10.1002/advs.20210532510.1002/advs.202105325 ↗
82. 10.1039/D2TB02004A10.1039/D2TB02004A ↗
83. 10.1016/j.actbio.2014.05.02310.1016/j.actbio.2014.05.023 ↗
84. 10.1016/j.biomaterials.2020.11992110.1016/j.biomaterials.2020.119921 ↗
85. 10.1038/nature2016810.1038/nature20168 ↗
86. 10.1083/jcb.20150605510.1083/jcb.201506055 ↗
87. 10.7554/eLife.3199310.7554/eLife.31993 ↗
88. 10.1074/jbc.M00387120010.1074/jbc.M003871200 ↗
89. 10.1126/scisignal.aaz526710.1126/scisignal.aaz5267 ↗
90. 10.1073/pnas.08106909810.1073/pnas.081069098 ↗
91. 10.1074/jbc.M30089920010.1074/jbc.M300899200 ↗
92. 10.1002/jbm.a.3549710.1002/jbm.a.35497 ↗